GlaxoSmithKline LLC et al v. Glenmark Generics Inc. USA
| GlaxoSmithKline LLC and SmithKline Beecham (Cork) Limited |
| Glenmark Generics Inc. USA |
| 1:2014cv00877 |
| July 3, 2014 |
| US District Court for the District of Delaware |
| Wilmington Office |
| New Castle |
| Leonard P. Stark |
| Patent |
| 35 U.S.C. ยง 145 |
| Plaintiff |
Follow case documents by RSS
Available Case Documents
The following documents for this case are available for you to view or download:
| Document Text |
|---|
Filing
342
MEMORANDUM ORDER re (383 in 1:14-cv-00878-LPS-CJB) REPORT AND RECOMMENDATION is ADOPTED, and the portion of Defendants' motion for summary judgment related to lost profits and the portion of Defendants' motion to exclude set forth herein (D.I. 248) are DENIED, and GSK's motions to exclude (Glenmark action D.I. 209; D.I. 246) are GRANTED. Signed by Judge Leonard P. Stark on 6/9/17. Associated Cases: 1:14-cv-00877-LPS-CJB, 1:14-cv-00878-LPS-CJB (ntl)
|
|
Filing
321
MEMORANDUM ORDER re (302 in 1:14-cv-00877-LPS-CJB, 351 in 1:14-cv-00878-LPS-CJB) REPORT AND RECOMMENDATION is ADOPTED and the portion of Defendants' motion for summary judgment related to convoyed sales is GRANTED. Signed by Judge Leonard P. Stark on 5/26/17. Associated Cases: 1:14-cv-00877-LPS-CJB, 1:14-cv-00878-LPS-CJB (ntl)
|
|
Filing
319
MEMORANDUM ORDER re (346 in 1:14-cv-00878-LPS-CJB) REPORT AND RECOMMENDATION is ADOPTED to the extent and as explained herein re Defendants' motion for summary judgment as related to invalidity is DENIED (248 in 1:14-cv-00878-LPS-CJB). Signed by Judge Leonard P. Stark on 5/25/17. Associated Cases: 1:14-cv-00877-LPS-CJB, 1:14-cv-00878-LPS-CJB (ntl)
|
|
Filing
251
MEMORANDUM ORDER re (165 in 1:14-cv-00878-LPS-CJB, 133 in 1:14-cv-00877-LPS-CJB) REPORT AND RECOMMENDATION re claim construction. Signed by Judge Leonard P. Stark on 2/17/17. Associated Cases: 1:14-cv-00877-LPS-CJB, 1:14-cv-00878-LPS-CJB (ntl)
|
|
Filing
186
REPORT AND RECOMMENDATION recommending DENYING D.I. 161 MOTION for Leave to File /Defendant Glenmark Pharmaceuticals Inc., USA's Motion For Leave To Amend Its Answer, Affirmative Defenses And Counterclaims filed by Glenmark Pharmac euticals Inc., USA. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 1/3/2017. Signed by Judge Christopher J. Burke on 12/15/2016. (mlc)
|
|
Filing
133
REPORT AND RECOMMENDATIONS regarding Claim Construction. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) and the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 6/20/2016. Signed by Judge Christopher J. Burke on 6/3/2016. Associated Cases: 1:14-cv-00877-LPS-CJB, 1:14-cv-00878-LPS-CJB(mlc)
|
|
Filing
54
MEMORANDUM ORDER re (38 in 1:14-cv-00877-LPS-CJB, 39 in 1:14-cv-00878-LPS-CJB) REPORT AND RECOMMENDATION -- Objections are OVERRULED and the Report is ADOPTED re (18 in 1:14-cv-00877-LPS-CJB) MOTION to Dismiss filed by Glenmark Generics Inc. USA; and (20 in 1:14-cv-00878-LPS-CJB) MOTION to Dismiss filed by Teva Pharmaceuticals USA, Inc. are GRANTED-IN-PART and DENIED-IN-PART. Signed by Judge Leonard P. Stark on 8/10/15. Associated Cases: 1:14-cv-00877-LPS-CJB, 1:14-cv-00878-LPS-CJB (ntl)
|
|
Filing
38
REPORT AND RECOMMENDATIONS recommending Granting in part D.I.(18 in 1:14-cv-00877-LPS-CJB) MOTION to Dismiss for Failure to State a Claim filed by Glenmark Generics Inc. USA, and D.I. (20 in 1:14-cv-00878-LPS-CJB) MOTION to Dismiss f or Failure to State a Claim filed by Teva Pharmaceuticals USA Inc.. Please note that when filing Objections pursuant to Federal Rule of Civil Procedure 72(b)(2), briefing consists solely of the Objections (no longer than ten (10) pages) an d the Response to the Objections (no longer than ten (10) pages). No further briefing shall be permitted with respect to objections without leave of the Court. Objections to R&R due by 5/11/2015. Signed by Judge Christopher J. Burke on 4/22/2015. Associated Cases: 1:14-cv-00877-LPS-CJB, 1:14-cv-00878-LPS-CJB(dlk)
|
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
